 |
 |
---------- > Fra: John Cottingham <[log in to unmask]> > Til: Multiple recipients of list PARKINSN <[log in to unmask]> > Emne: Re: DDB128 > Dato: 3. maj 1997 05:27 > > At 09:55 PM 5/2/97 -0400, you wrote: > >Bestwishes from Philip Dunn] > >[log in to unmask] > > > > > tolcapone / Tasmar (R) > ANTIPARKINSON: Dopamine agonist: TRIAL PHASE > > Tolcapone is the most potent COMT inhibitor currently > in clinical development. Studies in patients with Parkinson's > disease in the United States and Europe are complete. snip Tolcapone > should be an important development in the treatment of > Parkinson's disease. > snip > > > [log in to unmask] That man may last, but never lives, > Who much receives, but nothing gives; > HomeBoy #Parkinsons Whom none can love, whom none can thank, > Creation's blot, creation's blank. > John Cottingham Thomas Gibbons (1720-1785): > When Jesus dwelt. > > > Hello John, BUT WHEN? Here in Denmark we have been told SOON, but what is soon? is it month or a year? Do you know something about that? Best regards Sonia NEVER GIVE UP > > > > > > > >